Cajazeiro, D.C.; Toledo, P.P.M.; de Sousa, N.F.; Scotti, M.T.; Reimão, J.Q.
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii. Pharmaceutics 2022, 14, 1634.
https://doi.org/10.3390/pharmaceutics14081634
AMA Style
Cajazeiro DC, Toledo PPM, de Sousa NF, Scotti MT, Reimão JQ.
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii. Pharmaceutics. 2022; 14(8):1634.
https://doi.org/10.3390/pharmaceutics14081634
Chicago/Turabian Style
Cajazeiro, Débora Chaves, Paula Pereira Marques Toledo, Natália Ferreira de Sousa, Marcus Tullius Scotti, and Juliana Quero Reimão.
2022. "Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii" Pharmaceutics 14, no. 8: 1634.
https://doi.org/10.3390/pharmaceutics14081634
APA Style
Cajazeiro, D. C., Toledo, P. P. M., de Sousa, N. F., Scotti, M. T., & Reimão, J. Q.
(2022). Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii. Pharmaceutics, 14(8), 1634.
https://doi.org/10.3390/pharmaceutics14081634